SCOPE: Successful CO-Management between Primary Care and Endocrinology
 
Event Information
Saturday, December 7, 2019 • 8:00am–3:30pm
Hampton Inn Philadelphia – City Center Convention Center
1301 Race Street
Philadelphia, Pennsylvania
Untitled Document


CME Statement
The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AACE designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Live activity, SCOPE: Successful Co-management between Primary Care and Endocrinology, from 12/07/2019 - 03/07/2020, has been reviewed and is acceptable for up to 6.50 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This continuing nursing education activity was approved by Montana Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

Criteria for successful completion of this program includes completing the pre-test, participating in the conference, scoring 80% or higher on the post-test and completing the program evaluation.


Learning Objectives

  • Identify key aspects of the workup for the given endocrine disorder
  • Explain aspects of patient presentation and/or course that necessitate referral to an endocrinologist
  • Summarize key characteristics of evidence-based assessment and treatment options for the given disorder
  • Formulate a management plan that includes steps/strategies supporting optimal PCP-endocrinologist collaboration

 

Faculty Disclosures

  • Daniel Hurley, MD, has nothing to report.
  • Archana Sadhu, MD, FACE, serves on the speakers bureau for Sanofi Aventis.
  • Pamela Kushner, MD, serves as a consultant and on the speakers bureau for Astra Zeneca and Janssen. She also is a consultant for Lilly, Pfizer, and Novo Nordisk.
  • Deborah Hinnen, APN, BC-ADM, CDE, FAAN, FAADE, serves as consultant and on the speakers bureau from Lilly, Novo, Sanofi, Janssen.
  • Ji Chun, MD, PA-C, MPAS, BC-ADM, receives honorarium from Corcept.
  • Amy Defouw, MA, RD, CDE, has nothing to report.
  • Emily Welles, MS, RD, CDE, has nothing to report.


This program is supported by educational grants from AstraZeneca; Lilly USA, LLC; Novo Nordisk Inc.; and Pfizer-Merck Alliance.